TSPO 18 kDa (PBR) targeted photosensitizers for cancer imaging (PET) and PDT

ACS Medicinal Chemistry Letters

Volumn 2, Issue 2, 2011, Pages 136-141

  Chen, Yihui ^a,b   Sajjad, Munawwar ^b   Wang, Yanfang ^a   Batt, Carrie ^a   Nabi, Hani A ^b   Pandey, Ravindra K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

cancer target specific; peripheral benzodiazepine receptor (PBR); Photodynamic therapy (PDT); PK 11195; positron emission tomography (PET); translocator protein (TSPO)

Indexed keywords

3 [1' HEXYLOXYETHYL] 3 DEVINYL PYROPHEOPHORBIDE); MEMBRANE PROTEIN; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PHEOPHORBIDE; PHOTOSENSITIZING AGENT; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; DRUG STRUCTURE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 79951534507     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml100211g     Document Type: Article

References (31)

1. Papadopoulos, V.; Baraldi, M.; Guilarte, T. R.; Knudsen, T. B.; Lacapere, J.-J.; Lindemann, P.; Norenberg, M. D.; Nutt, D.; Weizman, A.; Zhang, M.-R.; Gavish, M. Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol. Sci. 2006, 27, 402-409 (Pubitemid 44069585)
2. Kessel, D.; Antolovich, M.; Smith, K. M. The Role of the Peripheral Benzodiazepine Receptor in the Apoptotic Response to Photodynamic Therapy Photochem. Photobiol. 2001, 74, 346-349
3. Taliani, S.; Settimo, F. D.; Pozzo, E. D.; Chelli, B.; Martini, C. Translocator Protein Ligands as Promising Therapeutic Tools for Anxiety Disorders Curr. Med. Chem. 2009, 16, 3359-3380
4. Naglar, R.; Savulescu, D.; Krayzler, E.; Leschiner, S.; Veenman, L.; Gavish, M. Cigarette Smoke Decreases Salivary 18 kDa Translocator Protein Binding Affinity̌In Association with Oxidative Stress Curr. Med. Chem. 2010, 17, 2539-2546
5. Gavish, M.; Bachman, I.; Shoukrun, R.; Katz, Y.; Veenman, L.; Weisinger, G.; Weizman, A. Enigma of the peripheral benzodiazepine receptor Pharmacol. Rev. 1999, 51, 629-650
6. Veenman, L.; Gavish, M. The peripheral-type benzodiazepine receptor and the cardiovascular system: implications for drug development Pharmacol. Ther. 2006, 110, 503-524
7. Veenman, L.; Papadopoulos, V.; Gavish, M. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response Curr. Pharm. Des. 2007, 13, 2385-2405 (Pubitemid 47321571)
8. Kugler, W.; Veenman, L.; Shandalov, Y.; Leschiner, S.; Spanier, I.; Lakomek, M.; Gavish, M. Ligands of the mitochondrial 18 kDa Translocator Protein attenuate apoptosis in human glioblastoma cells exposed to erucylphosphohomocholine Cell. Oncol. 2008, 30, 435-450
9. Shoukrun, R.; Veenman, L.; Shandalov, Y.; Leschiner, S.; Spanier, I.; Karry, R.; Katz, Y.; Weisinger, G.; Weizman, A.; Gavish, M. The 18 kDa Translocator Protein, formerly known as the peripheral-type benzodiazepine receptor, confers pro-apoptotic and antineoplastic effects in a human colorectal cancer cell line Pharmacogenet. Genomics 2008, 18, 977-988
10. Maaser, K.; Hopfner, M.; Jansen, A.; Weisinger, G.; Gavish, M.; Kozikowski, A. P. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells Br. J. Cancer 2001, 85, 1771-1780 (Pubitemid 34081526)
11. Sanger, N.; Strohmeier, R.; Kaufmann, M.; Kuhl, H. Cell cycle-related expression and ligand binding of peripheral benzodiazepine receptor in human breast cancer cell lines Eur. J. Cancer 2000, 36, 2157-2163
12. Sutter, A. P.; Maaser, K.; Höpfner, M.; Barthel, B.; Grabowski, P.; Faiss, S.; Carayon, P.; Zeitz, M.; Hans Scherubl, H. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human esophageal cancer cells Radiat. Oncol. Invest. 2002, 4, 318-327 (Pubitemid 35265870)
13. Hirsch, T.; Decaudin, D.; Susin, S. A.; Marchetti, P.; Larochette, N.; Resche-Rigon, M.; Kroemer, G. PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection Exp. Cell Res. 1998, 241, 426-434 (Pubitemid 28366568)
14. James, M. L.; Selleri, S.; Kassiou, M. Development of ligands for peripheral benzodiazepine receptor Curr. Med. Chem. 2006, 13, 1991-2001
15. Han, Z.; Slack, R. S.; Li, W. P.; Papadopoulos, V. Expression of Peripheral Benzodiazepine Receptor (PBR) in Human Tumors: Relationship to Breast, Colorectal, and Prostate Tumor Progression J. Recept. Signal Transduct. Res. 2003, 23, 225-238 (Pubitemid 37362242)
16. Huang, Z. A review of progress in clinical photodynamic therapy Technol. Cancer Res. Treat. 2005, 4, 283-293 (Pubitemid 40807688)
17. Mang, T. S.; Allison, R.; Hewson, G.; Snider, W.; Moskowitz, R. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer Cancer J. 1998, 6, 378-384
18. Cuenca, R. E.; Allison, R. R.; Sibata, C.; Downie, G. H. Breast cancer with chest wall progression: Treatment with photodynamic therapy Ann. Surg. Oncol. 2004, 11, 322-327 (Pubitemid 40486774)
19. Wyss, P.; Schwarz, V.; Dobler-Girdziunaite, D.; Hornung, R.; Walt, H.; Degen, A; Fehr, M. K. Photodynamic therapy of locoregional breast cancer recurrences using a chlorin-type photosensitizer Int. J. Cancer 2001, 93, 720-724 (Pubitemid 32695123)
20. Allison, R.; Mang, T.; Hewson, G.; Snider, W.; Dougherty, D. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality Cancer 2001, 91 (1) 1-8 (Pubitemid 32052607)
21. Quon, A.; Gambhir, S. S. FDG-PET and beyond: Molecular breast cancer imaging J. Clin. Oncol. 2005, 23, 1664-1673 (Pubitemid 46211421)
22. Fischer, B. M.; Olsen, M. W. B.; Ley, C. D.; Klausen, T. L.; Mortensen, J.; Hojgaard, L.; Kristjansen, P. E. G. How few cancer cells can be detected by positron emission tomography A frequent question addressed by an in vitro study Eur. J. Nucl. Med. Mol. Imaging 2006, 33, 697-702 (Pubitemid 43846761)
23. Kennedy, J. A.; Israel, O.; Frenkel, A.; Bar-Shalom, R.; Azhari, H. Super-Resolution in PET Imaging IEEE Trans. Med. Imaging 2006, 25, 137-147 (Pubitemid 43172568)
24. Pentlow, K. S.; Graham, M. C.; Lambrecht, R. M.; Daghighian, F.; Bacharach, S. L.; Bendriem, B.; Finn, R. D.; Jordon, K.; Kalaigian, H.; Karp, J. S.; Robeson, W. R.; Larson, S. M. Quantitive Imaging of Iodine-124 with PET J. Nucl. Med. 1996, 37, 1557-1562
25. Pandey, S. K.; Gryshuk, A.; Sajjad, M.; Zheng, X.; Chen, Y.; Abouzeid, M. M.; Morgan, J.; Charamisinau, I.; Nabi, H. A.; Oseroff, A.; Pandey, R. K. Multimodality Agents for Tumor Imaging (PET, Fluorescence) and Photodynamic Therapy. A Possible "See and Treat" Approach J. Med. Chem. 2005, 48, 6286-6295 (Pubitemid 41428983)
26. 123I]-Iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (3) in heart Nucl. Med. Biol. 1996, 23, 23-28
27. Mukhopadhyay, S.; Mukherjee, S.; Das, S. K. Increased expression of peripheral benzodiazepine receptor (PBR) in dimethylbenz[ a ]anthracene-induced mammary tumors in rats Glycoconj. J. 2006, 23, 199-207 (Pubitemid 43725199)
28. NCI website: http://ha.cancer.gov/cancertopics/types/breast.
29. Pappata, S.; Cornu, S.; Samson, Y.; Prenant, C.; Benavides, J.; Scatton, B.; Crouzel, C.; Hauw, J. J.; Syrota, A. PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report J. Nucl. Med. 1991, 32, 1608-1610
30. Chalon, S.; Pellevoisin, C.; Bodard, S.; Vilar, M.-P.; Besnard, J.-C.; Guilloteau, D. Iodinated PK 11195 as an ex vivo marker of neuronal injury in the lesioned rat brain Synapse 1996, 24, 334-339 (Pubitemid 26418685)
31. Hardwick, M.; Fertikh, D.; Culty, M.; Li, H.; Vidic, B.; Papadopoulos, V. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol Cancer Res. 1999, 59, 831-842 (Pubitemid 29086736)